Linaglite-M 2.5/1000 Tablet

Linagliptin 2.5 mg + Metformin 1000 mg

Linaglite-M 2.5/1000 Tablet — Linagliptin 2.5 mg + Metformin 1000 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Linagliptin 2.5 mg + Metformin 1000 mg
Dosage Form Tablet
Pack Type Box
Pack Size 10 x 10 (Blister)
MRP ₹ 1990
Therapy Cardiac + Diabetic — DPP-4 inhibitor + biguanide (FDC)
Storage Store below 25°C.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Linaglite-M 2.5/1000 Tablet

Linaglite-M 2.5/1000 Tablet combines Linagliptin 2.5 mg (DPP-4 inhibitor) with Metformin 1000 mg (biguanide). Twice-daily dosing of this combination provides Linagliptin 5 mg total and Metformin 2000 mg total — covering the standard recommended daily doses of both.

It is indicated for adults with type-2 diabetes inadequately controlled on metformin monotherapy or those switching from concurrent administration of separate tablets to a fixed-dose combination.

Camrut Healthcare manufactures Linaglite-M under WHO-GMP conditions for PCD pharma franchise across India.

Indications

  • Type-2 DM uncontrolled on metformin monotherapy
  • Patients already on Linagliptin + Metformin separately
  • Higher-dose biguanide requirement

Mechanism of Action

Linagliptin inhibits DPP-4, prolonging incretin activity to enhance glucose-dependent insulin secretion. Metformin activates AMPK, suppressing hepatic glucose output and improving peripheral insulin sensitivity. The combination addresses both insulin secretion and insulin resistance defects of T2DM.

Dosage & Administration

['Adults: 1 tablet twice daily, taken with meals', 'Swallow whole', 'Take with food to minimise GI side effects', 'Monitor renal function periodically']

Side Effects

['GI upset (metformin)', 'Nasopharyngitis', 'Metallic taste', 'Vitamin B12 deficiency (chronic metformin)', 'Lactic acidosis (very rare; avoid in renal impairment)']

Contraindications & Precautions

['Type-1 diabetes', 'Diabetic ketoacidosis', 'eGFR < 30 mL/min/1.73 m²', 'Severe hepatic impairment', 'Pregnancy and breastfeeding']

Storage

Store below 25°C.

PCD Pharma Franchise & Third-Party Manufacturing
Linaglite-M 2.5/1000 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

q

a

q

a

q

a

q

a

q

a

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.